Frisium 5 mg Tablets is a prescription medication formulated with Clobazam, a benzodiazepine commonly prescribed as an adjunct therapy for the management of epilepsy and certain neurological disorders. Manufactured by Sanofi India Limited, this medicine is recognized for its quality, safety, and effectiveness when used under proper medical supervision.
Clobazam acts on the central nervous system by enhancing the activity of gamma-aminobutyric acid (GABA), a naturally occurring neurotransmitter responsible for calming excessive neuronal activity in the brain. By stabilizing abnormal electrical impulses, it helps reduce the frequency and severity of seizures. This mechanism makes Frisium 5 mg Tablets an important therapeutic option for patients diagnosed with epilepsy, particularly those who require additional support alongside other antiepileptic drugs.
The 5 mg strength offers flexibility in dosage adjustment, allowing healthcare professionals to tailor treatment according to individual patient needs. It is often prescribed as an add-on therapy for conditions such as Lennox-Gastaut syndrome and other seizure disorders. Additionally, in certain cases, it may be recommended for managing anxiety-related conditions under strict medical guidance.
Frisium 5 mg Tablets are supplied in secure blister packaging that protects the medication from moisture and contamination while ensuring convenient and accurate dosing. The compact packaging makes it easy to store and carry, supporting consistent adherence to prescribed therapy.
Sanofi, the manufacturer of Frisium, is a globally respected pharmaceutical company known for its commitment to innovation, quality, and patient safety. Each tablet is produced under stringent quality control measures, ensuring reliability and efficacy.
Patients are advised to take this medication exactly as prescribed by their healthcare provider. Abrupt discontinuation should be avoided, as it may lead to withdrawal symptoms or an increase in seizure frequency. Gradual tapering under medical supervision is recommended when discontinuing the treatment.
While Frisium 5 mg Tablets are generally well-tolerated, some individuals may experience side effects such as drowsiness, dizziness, fatigue, or coordination difficulties. These effects are typically mild and may diminish as the body adjusts to the medication. However, any persistent or severe symptoms should be promptly reported to a healthcare professional.
This medicine is not suitable for self-medication and should only be used with a valid prescription. Individuals with a history of liver disease, respiratory disorders, or substance dependence should inform their doctor before starting treatment. Special precautions are also advised for pregnant or breastfeeding women.
Frisium 5 mg Tablets provide a dependable and clinically established option for managing epilepsy and related neurological conditions. With its proven efficacy, trusted manufacturer, and precise dosage, it remains a preferred choice among healthcare professionals for adjunctive seizure management.